FES and acute myeloid leukemia: To investigate whether each inhibitor was working through a mechanism in TF-1/Flt3-ITD cells similar to that observed in the Flt3-ITD+ AML cell lines, cells were treated with each compound at its calculated in vitro IC90 value for Fes (or Flt3-ITD for tandutinib).